CN112915054A

CN112915054A - Wet tissue solution, preparation method thereof and wet tissue

Info

Publication number: CN112915054A
Application number: CN202110165511.9A
Authority: CN
Inventors: 唐世君; 王晓明; 孙崇涛; 杜娟灵
Original assignee: Beijing Dishang Junrong New Material Co ltd; Dishang Group Co ltd; Weihai Textile Group Import And Export Co ltd; Weihai Deschamps Medical Technology Co Ltd
Current assignee: Beijing Dishang Junrong New Material Co ltd; Dishang Group Co ltd; Weihai Textile Group Import And Export Co ltd; Weihai Deschamps Medical Technology Co Ltd
Priority date: 2021-02-06
Filing date: 2021-02-06
Publication date: 2021-06-08

Abstract

The invention discloses a wet tissue solution, which solves the technical problems that the existing no-clean care products have strong smell and irritation, are easy to generate allergy, and cannot be used for independently cleaning and protecting hair and skin at the same time, and the wet tissue solution comprises the following raw materials in percentage by weight: 0.6-5% of lauroyl oat amino acid sodium coupling liquid, 0.5-5% of plant extract antibacterial mixed liquid, 0-0.5% of essence mixed liquid, 0.05-0.5% of caprylyl glycol and the balance of deionized water.

Description

Wet tissue solution, preparation method thereof and wet tissue

Technical Field

The application belongs to the technical field of daily sanitary products, and particularly relates to a wet tissue solution, a preparation method thereof and a wet tissue.

Background

In a state that modern people live at a fast pace, convenient and fast products such as floor sweeping robots, beauty balls and legs running, dish washing machines, electric toothbrushes and the like are endless, so that 'lazy economy' is derived, and meanwhile, the appearance of 'lazy series' washing and protecting products simplifies the complex washing and protecting flow, for example, washing and protecting steps are omitted for washing and protecting hair products, so that the time for washing, protecting and beautifying hair is greatly saved.

In addition, pregnant and lying-in women, old people of high age, postoperative patients, field exploration personnel and the like can not meet personal bathing requirements due to physical reasons or objective environmental conditions, and the cuticles on the surface of the skin can be accumulated to form various skin diseases without being cleaned for a long time, so that physical and psychological health is seriously affected. The appearance of the no-clean care products meets the cleaning and care requirements of the people, but the existing no-clean care products have large smell and irritation due to the use of additive components such as an emulsifier, a preservative and the like; the vegetable starch is used for adsorbing grease on the surface of the skin, so that the skin cleaning capability is not thorough, pores are easy to block, and the skin is allergic such as reddish skin; when the existing product is used for washing and protecting hair, the cleaning can be finished by adding water for dilution, and the independent washing and protecting work on the hair cannot be realized. Therefore, there is a need to develop a no-wash care product or method which has no irritation and sensitization and has independent hair and skin cleaning functions.

Disclosure of Invention

The invention discloses a wet tissue solution, a preparation method thereof and wet tissues thereof, and mainly aims to provide a no-wash care product which has no irritation and sensitization, and has independent hair cleaning and skin cleaning functions and a preparation method thereof by taking the wet tissues as carriers.

In order to achieve the purpose, the invention adopts the following technical scheme:

the wet tissue solution comprises the following raw materials in percentage by weight: 0.6-5% of lauroyl oat amino acid sodium coupling liquid, 0.5-5% of plant extract antibacterial mixed liquid, 0-0.5% of essence mixed liquid, 0.05-0.5% of caprylyl glycol and the balance of deionized water.

Preferably, 0.6-5% of the coupling solution of sodium lauroyl oat amino acid is a mixture of sodium lauroyl oat amino acid, decyl glucoside and butanediol, wherein the weight percentage of the sodium lauroyl oat amino acid is 0.1-1%, the weight percentage of the decyl glucoside is 0-0.5%, and the weight percentage of the butanediol is 0.5-3.5%.

Preferably, 0.5-5% of the plant extract antibacterial mixed solution is a mixture of cinnamon bark extract, folium artemisiae argyi extract, oriental cherry extract, poria cocos extract, isoamyl glycol and deionized water, wherein the weight percentage of the cinnamon bark extract is 0.1-0.5%, the weight percentage of the folium artemisiae argyi extract is 0.1-0.5%, the weight percentage of the oriental cherry extract is 0-0.5%, the weight percentage of the poria cocos extract is 0-0.5%, the weight percentage of the isoamyl glycol is 0.1-1%, and the weight percentage of the deionized water is 0.2-2%.

Preferably, 0-0.5% of the essence mixed solution is a mixture of jasmine essence, PPG-26-butanol polyether-26, PEG-40 hydrogenated castor oil and deionized water, wherein the weight percentage of the jasmine essence is 0-0.17%, the weight percentage of the PPG-26-butanol polyether-26 is 0-0.13%, the weight percentage of the PEG-40 hydrogenated castor oil is 0-0.1%, and the weight percentage of the deionized water is 0-0.1%.

A method for preparing a wet tissue solution comprises the following steps:

a) weighing 0.1-1 wt% of sodium lauroyl oat amino acid, 0-0.5 wt% of decyl glucoside and 0.5-3.5 wt% of butanediol; 0.1 to 0.5 percent of cinnamon bark extract, 0.1 to 0.5 percent of folium artemisiae argyi extract, 0 to 0.5 percent of cherry blossom extract, 0 to 0.5 percent of tuckahoe extract, 0.1 to 1 percent of isoprene glycol and 0.2 to 2 percent of deionized water; 0 to 0.17 percent of jasmine essence, 0 to 0.13 percent of PPG-26-butanol polyether-26, 0 to 0.1 percent of PEG-40 hydrogenated castor oil and 0 to 0.1 percent of deionized water; 0.05 to 0.5 percent of caprylyl glycol; the balance of deionized water for later use;

b) mixing and fully stirring 0.5-3.5 wt% of butanediol weighed in the step a) and 0-0.5 wt% of decyl glucoside at the temperature of 78-82 ℃, cooling to 60-65 ℃, adding 0.1-1 wt% of sodium lauroyl oat amino acid weighed in the step a), and fully stirring to obtain sodium lauroyl oat amino acid coupling liquid;

c) mixing 0.1-0.5 wt% of cinnamon bark extract, 0.1-0.5 wt% of folium artemisiae argyi extract, 0-0.5 wt% of oriental cherry extract and 0-0.5 wt% of poria cocos extract obtained in the step a) with 0.1-1 wt% of isoprene glycol and 0.2-2 wt% of deionized water, and fully stirring to obtain plant extraction antibacterial mixed solution;

d) fully stirring 0-0.13 weight percent of PPG-26-butanol polyether-26, 0-0.1 weight percent of PEG-40 hydrogenated castor oil and 0-0.1 weight percent of deionized water which are weighed in the step a) at normal temperature to obtain a mixed solution, and uniformly stirring 0-0.17 weight percent of jasmine essence which is weighed in the step a) and the mixed solution until the mixture is transparent to obtain an essence mixed solution;

e) sequentially adding the caprylyl glycol weighed in the step a), the plant extraction antibacterial mixed liquid obtained in the step c) and the essence mixed liquid obtained in the step d) into the lauroyl oat amino acid sodium coupling liquid obtained in the step b) at the temperature of below 40-45 ℃, fully stirring, adding the balance of deionized water, and fully stirring to obtain the wet tissue solution.

A wet wipe comprising a wet wipe substrate and a wet wipe solution as described in any of the above.

Preferably, the wet tissue substrate is non-woven fabric, and the non-woven fabric is cross pearl grain non-woven fabric.

Preferably, the wet tissue substrate and the wet tissue solution are mixed according to the weight ratio of 1: 1-1: 10, and after the wet tissue substrate is adsorbed to saturation, the wet tissue substrate is cut, folded and sealed into a packaging bag to obtain a finished wet tissue product.

Preferably, the longitudinal breaking strength of the non-woven fabric is more than or equal to 100N/5cm, the longitudinal breaking elongation is more than or equal to 60%, the transverse breaking strength is more than or equal to 50N/5cm, and the transverse breaking elongation is more than or equal to 40%.

The raw materials of the invention play the following main roles in the technical scheme:

the sodium lauroyl oat amino acid plays a role of a skin conditioner in the invention, has stronger cleaning capability and can finish the cleaning, washing and protecting work of skin and hair; decyl glucoside plays a role in a cleaning agent and a moisturizing agent, is low in irritation and stable, can reduce irritation of other surfactants, has a thickening effect, and can increase moisture retention; the butanediol plays the role of a solvent and a humectant in the invention, and has certain moisturizing performance on the skin; the cinnamon bark extract plays the roles of resisting bacteria and diminishing inflammation and tranquilizing and relieving pain, and is non-toxic and harmless; the folium artemisiae argyi extract plays a role in resisting bacteria and diminishing inflammation, and can be used as an antibacterial agent for cosmetics and oral hygiene products; the oriental cherry extract plays roles in resisting bacteria, oxidation and saccharification, preventing aging and having certain anti-inflammatory effect; the poria cocos extract plays a role in a skin conditioner, and has the effects of resisting bacteria and diminishing inflammation, has the effect of firming the skin, and has a good inhibition effect on various bacterial fungi; the isoprene glycol plays the roles of a humectant and a solvent, and has the effects of moisturizing skin and mild moisturizing; the jasmine essence plays a role of a spice, has faint scent and has the effect of resisting oxidation and aging; PPG-26-Butanethol-26 acts as an emulsifier in the present invention; the PEG-40 hydrogenated castor oil plays a role of a solubilizer and is smooth after being added; the caprylyl glycol plays a role of a softening agent, an antibacterial agent and a skin conditioner in the invention, has a bacteriostatic function, can play a role of moisturizing and softening, and achieves the effects of mildness and corrosion prevention; deionized water acts as a solvent in the present invention.

The invention has the beneficial effects that: the lauroyl oat amino acid sodium in the wet tissue solution has a conditioning effect on skin, and the prepared lauroyl oat amino acid sodium coupling solution is mild, clean and non-irritant, and can be applied to washing and protecting products for infants and the like; the plant extract antibacterial mixed liquor contains various plant extracts which have the antibacterial and anti-inflammatory effects and are safe and non-toxic, and the plant extract antibacterial mixed liquor does not contain additive components such as an emulsifier, a preservative and the like in the existing no-wash care products, has no irritation and sensitization to skin and hair of a human body, and ensures the use safety of the plant extract antibacterial mixed liquor.

Detailed Description

In order to make the technical problems, technical solutions and advantageous effects to be solved by the present invention more clearly apparent, the present invention will be further described in detail with reference to the following embodiments of the present invention. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.

Example 1:

the wet tissue solution comprises the following raw materials in percentage by weight: 0.6% of lauroyl oat amino acid sodium coupling liquid, 0.5% of plant extraction antibacterial mixed liquid, 0.05% of caprylyl glycol and 98.85% of deionized water.

The preparation method of the wet tissue solution comprises the following steps:

a) weighing 0.1 percent of sodium lauroyl oat amino acid and 0.5 percent of butanediol by weight percentage; 0.1% of cinnamon bark extract, 0.1% of folium artemisiae argyi extract, 0.1% of isoamyl glycol and 0.2% of deionized water; 0.05% of caprylyl glycol; 98.85% deionized water;

b) adding 0.5 weight percent of butanediol at the temperature of 80 ℃, mixing and fully stirring, cooling to 65 ℃, adding 0.1 weight percent of sodium lauroyl oat amino acid, mixing and fully stirring to obtain sodium lauroyl oat amino acid coupling liquid;

c) weighing 0.1 percent of cinnamon bark extract and 0.1 percent of folium artemisiae argyi extract, 0.1 percent of isoamyl glycol and 0.2 percent of deionized water, and fully mixing and stirring, wherein the mixing ratio of the isoamyl glycol to the deionized water is 1:2, so as to obtain plant extraction antibacterial mixed solution;

d) 0.05 percent by weight of octyl glycol and 0.5 percent by weight of plant extraction antibacterial mixed solution are sequentially added into 0.6 percent by weight of lauroyl oat amino acid sodium coupling solution at the temperature of below 40 ℃ and fully stirred, and then 98.85 percent by weight of deionized water is added and fully stirred to obtain the wet tissue solution.

In the embodiment, the wet tissue comprises a wet tissue substrate and a wet tissue solution, wherein the wet tissue substrate is non-woven fabric, the wet tissue substrate and the wet tissue solution are mixed according to the weight ratio of 1:6, and after the wet tissue substrate is adsorbed to saturation, the wet tissue substrate is cut, folded and sealed into a packaging bag to obtain a finished wet tissue product.

Example 2:

the wet tissue solution comprises the following raw materials in percentage by weight: 1.6 percent of lauroyl oat amino acid sodium coupling liquid, 1.7 percent of plant extraction antibacterial mixed liquid, 0.15 percent of essence mixed liquid, 0.1 percent of caprylyl glycol and 96.45 percent of deionized water.

a) weighing 0.4 percent of sodium lauroyl oat amino acid, 0.2 percent of decyl glucoside and 1 percent of butanediol by weight percentage; 0.3% of cinnamon bark extract, 0.3% of folium artemisiae argyi extract, 0.1% of oriental cherry extract, 0.1% of poria cocos extract, 0.3% of isoamyl glycol and 0.6% of deionized water; 0.05% of jasmine essence, 0.05% of PPG-26-butanol polyether-26, 0.03% of PEG-40 hydrogenated castor oil and 0.02% of deionized water; 0.1% of caprylyl glycol; 96.45% deionized water;

b) mixing 1 weight percent of butanediol and 0.2 weight percent of decyl glucoside at 82 ℃, fully stirring, cooling to 64 ℃, adding 0.4 weight percent of sodium lauroyl oat amino acid, and fully stirring to obtain sodium lauroyl oat amino acid coupling liquid;

c) weighing 0.3 percent of cinnamon bark extract, 0.3 percent of folium artemisiae argyi extract, 0.1 percent of cherry blossom extract and 0.1 percent of tuckahoe extract, mixing 0.3 percent of isoamyl glycol and 0.6 percent of deionized water in a ratio of 1:2, and fully stirring to obtain plant extraction antibacterial mixed solution;

d) at normal temperature, fully stirring 0.05 percent by weight of PPG-26-butanol polyether-26, 0.03 percent by weight of PEG-40 hydrogenated castor oil and 0.02 percent by weight of deionized water to obtain a mixed solution, and uniformly stirring 0.05 percent by weight of jasmine essence and the mixed solution to be transparent to obtain an essence mixed solution;

e) when the temperature is below 42 ℃, 0.1 percent by weight of octyl glycol, 1.7 percent by weight of plant extraction antibacterial mixed liquor and 0.15 percent by weight of essence mixed liquor are sequentially added into 1.6 percent by weight of sodium lauroyl oat amino acid coupling liquor and fully stirred, and then 96.45 percent by weight of deionized water is added and fully stirred to obtain wet tissue solution.

In the embodiment, the wet tissue comprises a wet tissue substrate and a wet tissue solution, wherein the wet tissue substrate is non-woven fabric, the wet tissue substrate and the wet tissue solution are mixed according to the weight ratio of 1:4, and after the wet tissue substrate is adsorbed to saturation, the wet tissue substrate is cut, folded and sealed into a packaging bag to obtain a finished wet tissue product.

Example 3:

the wet tissue solution comprises the following raw materials in percentage by weight: 2.5 percent of lauroyl oat amino acid sodium coupling liquid, 2.5 percent of plant extraction antibacterial mixed liquid, 0.3 percent of essence mixed liquid, 0.2 percent of caprylyl glycol and 94.5 percent of deionized water.

a) weighing 0.6 percent of sodium lauroyl oat amino acid, 0.4 percent of decyl glucoside and 1.5 percent of butanediol by weight percentage; 0.3% of cinnamon bark extract, 0.5% of folium artemisiae argyi extract, 0.1% of oriental cherry extract, 0.1% of poria cocos extract, 0.5% of isoamyl glycol and 1% of deionized water; 0.1% of jasmine essence, 0.1% of PPG-26-butanol polyether-26, 0.06% of PEG-40 hydrogenated castor oil and 0.04% of deionized water; 0.2% of caprylyl glycol; 94.5% deionized water;

b) mixing 1.5 weight percent of butanediol and 0.4 weight percent of decyl glucoside at the temperature of 78 ℃, fully stirring, cooling to 62 ℃, adding 0.6 weight percent of sodium lauroyl oat amino acid, and fully stirring to obtain sodium lauroyl oat amino acid coupling liquid;

c) weighing 0.3 percent of cinnamon bark extract, 0.5 percent of folium artemisiae argyi extract, 0.1 percent of oriental cherry extract and 0.1 percent of poria cocos extract, 0.5 percent of isoamyl glycol and 1 percent of deionized water according to the weight percentage, and fully mixing and stirring the materials, wherein the mixing ratio of the isoamyl glycol to the deionized water is 1:2, so as to obtain plant extraction antibacterial mixed liquid;

d) at normal temperature, fully stirring 0.1 weight percent of PPG-26-butanol polyether-26, 0.06 weight percent of PEG-40 hydrogenated castor oil and 0.04 weight percent of deionized water to obtain a mixed solution, and uniformly stirring 0.1 weight percent of jasmine essence and the mixed solution until the mixture is transparent to obtain an essence mixed solution;

e) 0.2 percent of octyl glycol, 2.5 percent of plant extraction antibacterial mixed liquor and 0.3 percent of essence mixed liquor are sequentially added into 2.5 percent of lauroyl oat amino acid sodium coupling liquor by weight percentage and fully stirred at the temperature of below 45 ℃, and then 94.5 percent of deionized water by weight percentage is added and fully stirred to obtain wet tissue solution.

In the embodiment, the wet tissue comprises a wet tissue substrate and a wet tissue solution, wherein the wet tissue substrate is non-woven fabric, the wet tissue substrate and the wet tissue solution are mixed according to the weight ratio of 1:2, and after the wet tissue substrate is saturated in adsorption, the wet tissue substrate is cut, folded and sealed into a packaging bag to obtain a finished wet tissue product.

Example 4:

the wet tissue solution comprises the following raw materials in percentage by weight: 3.7 percent of lauroyl sodium oat amino acid coupling liquid, 3.5 percent of plant extraction antibacterial mixed liquid, 0.4 percent of essence mixed liquid, 0.3 percent of caprylyl glycol and 92.1 percent of deionized water.

a) weighing 0.8 percent of sodium lauroyl oat amino acid, 0.4 percent of decyl glucoside and 2.5 percent of butanediol by weight percentage; 0.5% of cinnamon bark extract, 0.3% of folium artemisiae argyi extract, 0.3% of oriental cherry extract, 0.3% of poria cocos extract, 0.7% of isoamyl glycol and 1.4% of deionized water; 0.13% of jasmine essence, 0.11% of PPG-26-butanol polyether-26, 0.08% of PEG-40 hydrogenated castor oil and 0.08% of deionized water; 0.3% of caprylyl glycol; 92.1% deionized water;

b) mixing butanediol 2.5 wt% and decyl glucoside 0.4 wt% at 80 deg.C, stirring, cooling to 60 deg.C, adding sodium lauroyl oat amino acid 0.8 wt%, stirring thoroughly to obtain sodium lauroyl oat amino acid coupling solution;

c) weighing 0.5 percent of cinnamon bark extract, 0.3 percent of folium artemisiae argyi extract, 0.3 percent of cherry blossom extract and 0.3 percent of tuckahoe extract, mixing 0.7 percent of isoamyl glycol and 1.4 percent of deionized water in a ratio of 1:2, and fully stirring to obtain plant extraction antibacterial mixed solution;

d) at normal temperature, fully stirring 0.11 weight percent of PPG-26-butanol polyether-26, 0.08 weight percent of PEG-40 hydrogenated castor oil and 0.08 weight percent of deionized water to obtain a mixed solution, and uniformly stirring 0.13 weight percent of jasmine essence and the mixed solution until the mixture is transparent to obtain an essence mixed solution;

e) 0.3 percent of octyl glycol, 3.5 percent of plant extraction antibacterial mixed liquor and 0.4 percent of essence mixed liquor are sequentially added into 3.7 percent of lauroyl oat amino acid sodium coupling liquor by weight percent at the temperature of below 41 ℃ and fully stirred, and then 92.1 percent of deionized water by weight percent is added and fully stirred to obtain wet tissue solution.

In the embodiment, the wet tissue comprises a wet tissue substrate and a wet tissue solution, wherein the wet tissue substrate is non-woven fabric, the wet tissue substrate and the wet tissue solution are mixed according to the weight ratio of 1:8, and after the wet tissue substrate is saturated in adsorption, the wet tissue substrate is cut, folded and sealed into a packaging bag to obtain a finished wet tissue product.

Example 5:

the wet tissue solution comprises the following raw materials in percentage by weight: 5% of lauroyl oat amino acid sodium coupling liquid, 5% of plant extraction antibacterial mixed liquid, 0.5% of essence mixed liquid, 0.5% of caprylyl glycol and 89% of deionized water.

a) weighing 1 percent of sodium lauroyl oat amino acid, 0.5 percent of decyl glucoside and 3.5 percent of butanediol by weight percentage; 0.5% of cinnamon bark extract, 0.5% of folium artemisiae argyi extract, 0.5% of oriental cherry extract, 0.5% of poria cocos extract, 1% of isoamyl glycol and 2% of deionized water; 0.17% of jasmine essence, 0.13% of PPG-26-butanol polyether-26, 0.1% of PEG-40 hydrogenated castor oil and 0.1% of deionized water; 0.5% of caprylyl glycol; 89% deionized water;

b) mixing 3.5 percent by weight of butanediol and 0.5 percent by weight of decyl glucoside at the temperature of 80 ℃, fully stirring, cooling to 60 ℃, adding 1 percent by weight of sodium lauroyl oat amino acid, fully stirring to obtain sodium lauroyl oat amino acid coupling liquid;

c) weighing 0.5 percent of cinnamon bark extract, 0.5 percent of folium artemisiae argyi extract, 0.5 percent of cherry blossom extract and 0.5 percent of tuckahoe extract, mixing 1 percent of isoprene glycol and 2 percent of deionized water in a mixing ratio of 1:2, and fully stirring to obtain plant extraction antibacterial mixed solution;

d) at normal temperature, fully stirring 0.13 weight percent of PPG-26-butanol polyether-26, 0.1 weight percent of PEG-40 hydrogenated castor oil and 0.1 weight percent of deionized water to obtain a mixed solution, and uniformly stirring 0.17 weight percent of jasmine essence and the mixed solution until the mixture is transparent to obtain an essence mixed solution;

e) when the temperature is below 44 ℃, 0.5 weight percent of octyl glycol, 5 weight percent of plant extraction antibacterial mixed liquor and 0.5 weight percent of essence mixed liquor are sequentially added into 5 weight percent of sodium lauroyl oat amino acid coupling liquor and fully stirred, and then 89 weight percent of deionized water is added and fully stirred to obtain wet tissue solution.

In the embodiment, the wet tissue comprises a wet tissue substrate and a wet tissue solution, wherein the wet tissue substrate is non-woven fabric, the wet tissue substrate and the wet tissue solution are mixed according to the weight ratio of 1:10, and after the wet tissue substrate is saturated in adsorption, the wet tissue substrate is cut, folded and sealed into a packaging bag to obtain a finished wet tissue product.

In the embodiment, butanediol and decyl glucoside are mixed and fully stirred at the temperature of 78-82 ℃, and when the temperature is reduced to 60-65 ℃, sodium lauroyl oat amino acid is added and fully stirred to obtain sodium lauroyl oat amino acid coupling liquid; at normal temperature, fully stirring the weighed PPG-26-butanol polyether-26, PEG-40 hydrogenated castor oil and deionized water to obtain a mixed solution; when the temperature is below 40-45 ℃, octyl glycol, plant extraction antibacterial mixed liquor and essence mixed liquor are sequentially added into the lauroyl oat amino acid sodium coupling liquid and are fully mixed to obtain wet tissue solution, substances used in each step can be fully dissolved within the temperature range or the temperature value selected in each step, if the temperature is higher than the range value, corresponding components are inactivated, the original efficacy cannot be exerted, and the normal operation of the preparation process of the wet tissue and the wet tissue solution can be influenced.

In the embodiment, the three raw material components of the obtained lauroyl oat amino acid sodium coupling liquid, the plant extraction antibacterial mixed liquid and the essence mixed liquid are weighed according to the component weight, when the water temperature is below 40-45 ℃, the caprylyl glycol, the plant extraction antibacterial mixed liquid and the essence mixed liquid are sequentially added into the lauroyl oat amino acid sodium coupling liquid, the caprylyl glycol has the function of a bacteriostatic agent, the bacteriostatic agent with chemical components is added firstly for full dissolution, the plant extraction antibacterial mixed liquid with the bacteriostatic effect is added, and after full stirring and uniform mixing, the essence mixed liquid is added finally for seasoning; if the octyl glycol, the plant extract antibacterial mixed liquor and the essence mixed liquor are not added in sequence, the stability of the wet tissue solution is affected, certain influence is generated on the service performance of the prepared wet tissue product, the adding sequence of different materials in each step is considered, and all the materials can have sufficient solubility, so that the wet tissue solution with better service performance and the wet tissue finished product are obtained.

The common no-clean products in the market relate to skin cleaning and mainly are wet tissues, and have the following defects: the moisturizing component mainly containing glycerin and plant extract cannot play an effective cleaning role, and the phenomenon of skin redness and the like is easily caused by easily wiping off grease with a protective effect on the surface of the skin in the use process. The similar product on the market is protein water-free wiping bath foam suitable for Spongia, the invention patent number is CN201711035668, grease can be effectively cleaned, but in the using process, the wiping is performed by soaking a towel after the dilution with water is needed, the convenience is low, and the using steps are troublesome; for the invention, the finished product of the wet tissue is directly taken out to wipe and clean the skin by opening the packaging bag, which is convenient and quick, and meets the use requirements of consumers on the no-wash products to a certain extent.

The finished wet tissue product prepared by the embodiment of the invention is tested by the Western-Ans Union of China quality testing technology, Inc. (bacteriostasis performance test), and the sample is a sheet-shaped and bulk product.

1. Skin irritation test

The skin irritation detection is carried out on the finished wet tissue product through a one-time complete skin irritation experiment, and the experiment method comprises the following steps: the two sides of the spinal column of 10 rabbits are removed 24 hours before the experiment, the epidermis cannot be damaged, the hair removal range is about 3cm multiplied by 3cm, the finished wet tissue products prepared in the examples 1 to 5 and the comparative wet tissues 1 to 5 are respectively and directly smeared on the hair removal skin on one side of the rabbit, one wet tissue is used for smearing each rabbit, the quality of the wet tissue solution smeared on each rabbit is controlled to be 0.5g, the wet tissue solution is covered with gauze and fixed by a non-irritant bandage after smearing, the residual test object is removed by warm water after 4 hours of smearing, the wet tissue solution is smeared once every day for 14 days continuously, and the result is observed 24 hours after each smearing. The observation indexes are as follows: the skin of the application site was observed daily for erythema and edema formation, scored according to the degree of reaction, and the mean score for each animal was calculated over 14 days, and the results are shown in table 1:

table 1 animal skin test results table

	Erythema	Edema (edema)
			Example 1	0	0
Example 2	0	0
			Example 3	0	0
Example 4	0	0
			Example 5	0	0
Comparative example 1	3	1
			Comparative example 2	2	2
Comparative example 3	3	4
			Comparative example 4	1	3
Comparative example 5	3	2

Grading standard:

erythema formation: 0 is absent, 1 is barely visible, 2 is obvious, 3 is severe, 4 is purplish red erythema with eschar;

edema formation: 0 is absent, 1 is barely visible, 2 is skin doming, well defined, 3 is edema doming about 1mm, 4 is edema doming over 1 mm.

Multiple complete skin irritation experiments show that: the wet tissue solution obtained from the examples 1 to 5 has skin irritation of rabbits with an average value of 0 integrated per animal per day, and the experiment is based on the skin irritation intensity classification standard in disinfection technical specification (2002 edition of Ministry of health) 2.3.3, and is non-irritant.

2. Test of bacteriostatic Property

Name of the experimental strain: escherichia coli, strain number: 8099; staphylococcus aureus, strain number: ATCC6538, strain passage number: the third generation; candida albicans, strain number: ATCC 10231, strain passage number: the third generation; the strain source is as follows: ATCC (American ginseng).

According to the test according to GB 15979-2002 hygienic Standard for Disposable sanitary articles, the test method comprises washing slant culture of test bacteria for 24 hr with PBS to obtain bacterial suspension (required concentration: 100 μ L is dropped on wet towel of comparative example or 5mL, and the number of recovered bacteria is 1 × 10)⁴～9×10⁴cfu/tablet or mL).

The finished wet tissue products (2.0cm multiplied by 3.0cm) or wet tissue solution (5mL) prepared in the examples 1-5 and the comparative wet tissue or wet tissue solution are taken, and each of the wet tissue or wet tissue solution is taken as 4 pieces (placed in a sterilized plate) or 4 tubes.

And (3) taking the bacterial suspension, respectively dripping 100 mu L of the bacterial suspension on or in each of the wet tissue finished products or wet tissue solutions of examples 1-5 and the comparative wet tissue finished products or wet tissue solutions, uniformly coating/mixing, starting timing, acting for 2, 5, 10 and 20 minutes, respectively putting the wet tissues or wet tissue solutions (0.5mL) into a test tube containing 5mL of PBS by using sterile forceps, fully mixing, appropriately diluting, then taking 2-3 dilutions, respectively sucking 0.5mL, putting the diluted solutions into two plates, pouring 15mL of nutrient agar medium (bacteria) or Sabouraud's agar medium (yeast) cooled to 40-45 ℃, rotating the plates to fully and uniformly stir the plates, culturing for 48 hours (bacteria) or 72 hours (yeast) at 35 +/-2 ℃ after agar is solidified, and counting viable bacteria colonies.

The experiment was repeated 3 times, and the bacteriostatic rate was calculated according to the following formula, and the results are shown in table 2:

X＝(A-B)/A×100％

in the formula: x-bacteriostasis rate,%;

a-average colony number of comparative wet tissue;

b-average colony count of finished wet wipes of examples 1 to 5.

Table 2 bacteriostatic property test result table

Evaluation criteria:

the bacteriostatic rate is more than or equal to 50-90%, the product has bacteriostatic action, the bacteriostatic rate is more than or equal to 90%, and the product has strong bacteriostatic action.

The antibacterial performance test shows that: the total bacterial colony count and the total fungal colony count are both less than 20CFU/g, the action time is 2 minutes, 5 minutes, 10 minutes and 20 minutes respectively, the test is repeated for 3 times, the bacteriostasis rate to escherichia coli (8099), staphylococcus aureus (ATCC 6538) and candida albicans (ATCC 10231) is more than 90 percent respectively, the bacteriostatic action to the tested strain is stronger, and the requirement of GB 15979 plus 2002 hygienic Standard for Disposable sanitary articles is met.

3. Sensory testing

The wet tissue obtained by the preparation method is taken as an experimental sample to evaluate the efficacy of the human body, and the efficacy evaluation method of the hair wet tissue liquid prepared in the embodiment adopts a sensory evaluation method, wherein the sensory evaluation method comprises the following steps: the finished wet wipes prepared in examples 1-5 and the comparative wet wipes were distributed to 60 testers with similar hair style and hair amount, and the testers were divided into 6 groups, and 10 persons in each group were compared for use. When a tester uses a sample, the skin and the hair on the back of the hand are uniformly wiped clean by the wet tissue according to the same using method, the tester scores according to the self feeling, the scoring standard is divided into 10 points, 1 point is the worst, and 10 points are the best, the cleaning capability refers to the capability of the wet tissue for removing dust and dirt on the skin and the hair, and the stronger the capability of removing the dust and dirt, the higher the score is; the use feeling refers to the amount of foam on the skin and hair and whether the hand feeling is greasy or not when the wet tissue is used, the less the foam, the less sticky the hand feeling and the higher the score; mildness refers to whether skin and hair can generate irritation when the wet tissue is used, and the smaller the irritation, the higher the score; the drying speed refers to the natural air drying speed of the skin and the hair after the wet tissue is used, and the higher the natural air drying speed is, the higher the score is. The average score of the test persons for each sensory evaluation result is shown in table 3:

TABLE 3 sensory evaluation results of the testers

	Cleaning ability	Feeling of use	Mildness property	Drying speed
					Example 1	8	9	9	8
Example 2	9	8	9	9
					Example 3	8	9	8	8
Example 4	9	8	7	7
					Example 5	9	9	8	7
Comparative example	4	5	4	/

Sensory evaluation tests show that: the wet tissue disclosed by the invention can effectively clean dust and dirt on skin and hair, is good in use feeling, basically free of bubbles, not sticky and greasy in hand feeling, refreshing after use, short in retention time of liquid on hair, and high in natural air drying speed of hair, and has the advantages that the amount of liquid on the hair is less due to proper control of the liquid content, the next social activity can be carried out even if the hair is not completely dried, and the comparative wet tissue far cannot meet the requirement, so that the cleaning and washing work of the hair cannot be completed.

The comparative wet wipes used in the above experimental tests were all commercially available common wet wipe products.

The above description is only a preferred embodiment of the present invention, the present invention is not limited to the above-described embodiment, and there may be some slight structural changes in the implementation, and if various changes or modifications of the present invention do not depart from the spirit and scope of the present invention and fall within the claims and equivalent technical scope of the present invention, the present invention is intended to include such changes and modifications.

Claims

1. The wet tissue solution is characterized by comprising the following raw materials in percentage by weight: 0.6-5% of lauroyl oat amino acid sodium coupling liquid, 0.5-5% of plant extract antibacterial mixed liquid, 0-0.5% of essence mixed liquid, 0.05-0.5% of caprylyl glycol and the balance of deionized water.

2. A wet wipe solution as set forth in claim 1 wherein 0.6% to 5% of the sodium lauroyl oat amino acid coupling solution is a mixture of sodium lauroyl oat amino acid, decyl glucoside, and butylene glycol, wherein the sodium lauroyl oat amino acid is present in an amount of 0.1% to 1% by weight, the decyl glucoside is present in an amount of 0% to 0.5% by weight, and the butylene glycol is present in an amount of 0.5% to 3.5% by weight.

3. The wet towel solution according to claim 1, wherein 0.5-5% of the plant-extracted antibacterial mixed solution is a mixture of cinnamon bark extract, argyi leaf extract, cherry blossom extract, poria cocos extract, isoprene glycol and deionized water, wherein the cinnamon bark extract is 0.1-0.5% by weight, the argyi leaf extract is 0.1-0.5% by weight, the cherry blossom extract is 0-0.5% by weight, the poria cocos extract is 0-0.5% by weight, the isoprene glycol is 0.1-1% by weight, and the deionized water is 0.2-2% by weight.

4. The wet tissue solution as claimed in claim 1, wherein 0% to 0.5% of the essence mixture is a mixture of jasmine essence, PPG-26-Butanethol-26, PEG-40 hydrogenated castor oil, and deionized water, wherein the weight percentage of the jasmine essence is 0% to 0.17%, the weight percentage of the PPG-26-Butanethol-26 is 0% to 0.13%, the weight percentage of the PEG-40 hydrogenated castor oil is 0% to 0.1%, and the weight percentage of the deionized water is 0% to 0.1%.

5. A method of making the wet wipe solution of any one of claims 1-4 comprising the steps of:

b) mixing and fully stirring 0.5-3.5 wt% of butanediol and 0-0.5 wt% of decyl glucoside which are weighed in the step a), then adding 0.1-1 wt% of sodium lauroyl oat amino acid which is weighed in the step a), and fully stirring to obtain sodium lauroyl oat amino acid coupling liquid;

d) fully stirring 0-0.13 weight percent of PPG-26-butanol polyether-26, 0-0.1 weight percent of PEG-40 hydrogenated castor oil and 0-0.1 weight percent of deionized water which are weighed in the step a) to obtain a mixed solution, and uniformly stirring 0-0.17 weight percent of jasmine essence weighed in the step a) and the mixed solution until the mixture is transparent to obtain an essence mixed solution;

e) sequentially adding the caprylyl glycol weighed in the step a), the plant extraction antibacterial mixed liquid obtained in the step c) and the essence mixed liquid obtained in the step d) into the sodium lauroyl oat amino acid coupling liquid obtained in the step b), fully stirring, adding the balance of deionized water, and fully stirring to obtain the wet tissue solution.

6. The method for preparing a wet towel solution according to claim 5, wherein the butanediol and decyl glucoside are mixed and stirred sufficiently at a temperature of 78-82 ℃, the sodium lauroyl oat amino acid is added and stirred sufficiently when the temperature is reduced to 60-65 ℃, and the coupling solution of the sodium lauroyl oat amino acid is obtained; at normal temperature, fully stirring the weighed PPG-26-butanol polyether-26, PEG-40 hydrogenated castor oil and deionized water to obtain a mixed solution, and uniformly stirring the jasmine essence and the mixed solution until the mixed solution is transparent to obtain an essence mixed solution; and when the temperature is below 40-45 ℃, sequentially adding the caprylyl glycol, the plant extraction antibacterial mixed solution and the essence mixed solution into the sodium lauroyl oat amino acid coupling solution, and fully mixing and stirring to obtain the wet tissue solution.

7. A wet wipe comprising a wet wipe substrate characterized in that it further comprises a wet wipe solution as claimed in any one of claims 1 to 4.

8. The wet tissue as claimed in claim 7, wherein the wet tissue substrate is a non-woven fabric, and the non-woven fabric is a cross pearl grain non-woven fabric.

9. The wet tissue as claimed in claim 7, wherein the wet tissue substrate and the wet tissue solution are mixed according to a weight ratio of 1:1 to 1:10, and after the wet tissue substrate is saturated in adsorption, the wet tissue substrate is cut, folded and sealed into a packaging bag to obtain the finished wet tissue.

10. The wet wipe as set forth in claim 8 wherein the nonwoven fabric has a longitudinal breaking strength of not less than 100N/5cm, a longitudinal elongation at break of not less than 60%, a transverse breaking strength of not less than 50N/5cm, and a transverse elongation at break of not less than 40%.